Clinical Trials Browser

Phase 2 × Not yet recruiting × Thoracic × Clear all

NCT07545213 2026-04-22

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07158489 2026-04-21

ORIGIN2

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07379398 2026-04-21

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

NSCLC

NCT07543172 2026-04-21

CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07169617 2026-04-20

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07538258 2026-04-20

Aurora004

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT07538271 2026-04-20

Aurora 005

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT07501169 2026-04-13

STAR-01

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT07517640 2026-04-08

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07518160 2026-04-08

JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT07514793 2026-04-07

Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma

NCT06706219 2026-04-03

Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07507188 2026-04-02

INSTAR

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07500285 2026-03-31

Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06809946 2026-03-30

DEFLECT I

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07438600 2026-03-27

TianjinCIH

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07493980 2026-03-27

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07492121 2026-03-25

GAPIMET

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT06943664 2026-03-24

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07489703 2026-03-24

SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07489716 2026-03-24

A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07486817 2026-03-23

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07489066 2026-03-23

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Phase 2 Not yet recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT07482605 2026-03-20

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT07485452 2026-03-20

OSIBBBOOST

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT07001995 2026-03-16

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07472478 2026-03-16

GIVEN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07322341 2026-03-13

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07452224 2026-03-12

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07465757 2026-03-12

ALISCA-Lung2

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT07463677 2026-03-11

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07459634 2026-03-10

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06634056 2026-03-04

P4-PACIFIC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06813664 2026-03-04

CURB-TKI

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07402343 2026-03-04

T-BRAIN

Phase 2 Not yet recruiting

Brain Neoplasms, Small Cell Lung Carcinoma

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07444437 2026-03-03

LM103 in Phase IIa Clinical Trial for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Phase 2 Not yet recruiting

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07432984 2026-02-25

FMT-LUNG

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07418866 2026-02-18

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07418931 2026-02-18

CECYDE

Phase 2 Not yet recruiting

Advanced Squamous Non-Small Cell Lung Cancer

NCT07412262 2026-02-17

A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07413952 2026-02-17

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

Phase 2 Not yet recruiting

NSCLC

NCT07415005 2026-02-17

Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Advanced Non-Small Cell Lung Cancer

NCT07416058 2026-02-17

PHOENIX

Phase 2 Not yet recruiting

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

NCT07410611 2026-02-13

ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07405086 2026-02-12

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07405190 2026-02-12

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07234058 2026-02-11

LAG-MAPS

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant